Insider Transactions in Q4 2022 at Prelude Therapeutics Inc (PRLD)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2022
|
Krishna Vaddi CEO |
BUY
Open market or private purchase
|
Indirect |
19,188
+13.72%
|
$95,940
$5.13 P/Share
|
|
Dec 08
2022
|
Laurent Chardonnet Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+21.8%
|
$40,000
$4.76 P/Share
|